Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Karsten Nysom, Nicolas U. Gerber et al.|Journal of Clinical Oncology|2024Cited by 25
Bedside intra‐aortic balloon pump insertion in cardiac intensive care unit: A single‐center experienceLuca Baldetti, Alberto Cappelletti, Alessandro Beneduce et al.|Catheterization and Cardiovascular Interventions|2022Cited by 10
Longitudinal Invasive Hemodynamic Assessment in Patients With Acute Decompensated Heart Failure–Related Cardiogenic Shock: A Single-Center ExperienceLuca Baldetti, Alberto Cappelletti, Stefania Sacchi et al.|Circulation Heart Failure|2022Cited by 9
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C. Gray, Lucas Moreno, Rebekah Weston et al.|Journal of Clinical Oncology|2025Cited by 8